The Medicines (Products for Human Use) (Fees) Regulations 2016 No. 190

SCHEDULES

SCHEDULE 2 U.K. Capital fees for applications for, and variations to, marketing authorisations, licences, registrations and certificates

PART 4 U.K. Capital Fees for Applications for Variations of Authorisations, Licences and Registrations

Clinical trial authorisations U.K.

49.—(1) A fee of £225 is payable under regulation 20(2)(a) in connection with a notice of amendment relating to an amendment to the dossier, or to the protocol, related to a request for authorisation to conduct a clinical trial.